China-Biotics, a major developer, manufacturer and distributor of probiotics in China, has appointed Dr. Hui S. Chang as Chief Operating Officer, effective immediately.
Dr. Chang brings 15 years of biopharmaceutical project management experience and excellent research capabilities.
Prior to joining China-Biotics, Dr. Chang served as the president of a consulting service for a Sino-US joint biopharmaceutical program, where he led the scientific design, development, clinical trials, production and quality control for viral vaccines and antibodies.
He reported to the State Administration of Foreign Experts Affairs and played a key role in generating profits on the completed contract.
Dr. Chang was previously a senior manager of Nabi Biopharmaceuticals, where he supervised the development and production of bacterial and viral vaccines, developed biological potency and immunological methods and managed the development of assays for quality control and clinical testing.
Earlier, Dr. Chang served as a manager at Vaccinnate, a North American bio-vaccine company, was a research scientist with Cambridge Biotech, and started his professional career at North AM VAC Inc. in 1989.
engages in the research, development, marketing and distribution of probiotics dietary supplements in China.
Currently, the retail products are sold OTC mainly through large distributors to pharmacies and supermarkets in Shanghai, Jiangsu, and Zhejiang province.
The Company also sells bulk products to institutional customers such as dairy and animal feed producers, as well as pharmaceutical companies.